CXCL3 Human 1-nitropyrene increases expression EXP 6480464 1-nitropyrene results in increased expression of CXCL3 mRNA CTD PMID:19428942 and PMID:19879285 CXCL3 Human 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of CXCL3 mRNA CTD PMID:16298037 CXCL3 Human 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of CXCL3 mRNA CTD PMID:22574217 CXCL3 Human 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:23146750 CXCL3 Human 2,2',5,5'-tetrachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:36804509 CXCL3 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CXCL3 mRNA CTD PMID:22298810 CXCL3 Human 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CXCL3 mRNA CTD PMID:28628672 CXCL3 Human 3-Nitrofluoranthene increases expression EXP 6480464 3-nitrofluoranthene results in increased expression of CXCL3 mRNA CTD PMID:19879285 CXCL3 Human 4,4'-sulfonyldiphenol increases expression EXP 6480464 bisphenol S results in increased expression of CXCL3 mRNA CTD PMID:38568856 CXCL3 Human 4-aminobenzhydrazide multiple interactions EXP 6480464 4-aminobenzhydrazide inhibits the reaction [hydroxyhydroquinone results in increased expression of CXCL3 mRNA] CTD PMID:24530881 CXCL3 Human 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of CXCL3 mRNA CTD PMID:15958647 CXCL3 Human 6alpha-methylprednisolone decreases expression EXP 6480464 Methylprednisolone results in decreased expression of CXCL3 mRNA CTD PMID:19192274 CXCL3 Human aflatoxin M1 decreases expression EXP 6480464 Aflatoxin M1 results in decreased expression of CXCL3 mRNA CTD PMID:30928695 CXCL3 Human aldehydo-D-glucose multiple interactions EXP 6480464 Captopril inhibits the reaction [Glucose results in increased expression of CXCL3 mRNA] and huai qi huang inhibits the reaction [Glucose results in increased expression of CXCL3 mRNA] CTD PMID:38115276 CXCL3 Human aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of CXCL3 mRNA CTD PMID:38115276 CXCL3 Human anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone promotes the reaction [IL1A protein results in increased expression of CXCL3 mRNA] CTD PMID:12832416 CXCL3 Human antirheumatic drug decreases expression EXP 6480464 Antirheumatic Agents results in decreased expression of CXCL3 mRNA CTD PMID:24449571 CXCL3 Human aripiprazole multiple interactions EXP 6480464 [Aripiprazole co-treated with Ozone] results in increased expression of CXCL3 mRNA CTD PMID:31476115 CXCL3 Human arsane decreases expression EXP 6480464 Arsenic results in decreased expression of CXCL3 mRNA CTD PMID:16835338 CXCL3 Human arsenic atom decreases expression EXP 6480464 Arsenic results in decreased expression of CXCL3 mRNA CTD PMID:16835338 CXCL3 Human atrazine increases expression EXP 6480464 Atrazine results in increased expression of CXCL3 mRNA CTD PMID:22378314 CXCL3 Human benzene-1,2,4-triol increases expression EXP 6480464 hydroxyhydroquinone results in increased expression of CXCL3 mRNA CTD PMID:24530881 CXCL3 Human benzene-1,2,4-triol multiple interactions EXP 6480464 4-aminobenzhydrazide inhibits the reaction [hydroxyhydroquinone results in increased expression of CXCL3 mRNA] CTD PMID:24530881 CXCL3 Human benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of CXCL3 mRNA CTD PMID:20064835 CXCL3 Human benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of CXCL3 3' UTR CTD PMID:27901495 CXCL3 Human benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of CXCL3 mRNA CTD PMID:22316170 CXCL3 Human benzo[a]pyrene diol epoxide I affects expression EXP 6480464 7 more ... CTD PMID:20382639 CXCL3 Human beryllium sulfate increases expression EXP 6480464 beryllium sulfate results in increased expression of CXCL3 mRNA CTD PMID:16314022 CXCL3 Human beta-lapachone increases expression EXP 6480464 beta-lapachone results in increased expression of CXCL3 mRNA CTD PMID:38218311 CXCL3 Human beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of CXCL3 mRNA CTD PMID:32151702 CXCL3 Human bicalutamide increases expression EXP 6480464 bicalutamide results in increased expression of CXCL3 mRNA CTD PMID:15638997 CXCL3 Human bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CXCL3 mRNA CTD PMID:20170705 CXCL3 Human bisphenol F multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CXCL3 mRNA CTD PMID:28628672 CXCL3 Human butanal increases expression EXP 6480464 butyraldehyde results in increased expression of CXCL3 mRNA CTD PMID:26079696 CXCL3 Human Butylparaben increases expression EXP 6480464 butylparaben results in increased expression of CXCL3 mRNA CTD PMID:17121429 CXCL3 Human cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of CXCL3 mRNA CTD PMID:20105457 and PMID:21120746 CXCL3 Human cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of CXCL3 mRNA CTD PMID:26472689 CXCL3 Human cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of CXCL3 mRNA CTD PMID:38568856 CXCL3 Human calcitriol increases expression EXP 6480464 Calcitriol results in increased expression of CXCL3 mRNA CTD PMID:26485663 CXCL3 Human cannabidiol increases expression EXP 6480464 Cannabidiol results in increased expression of CXCL3 mRNA CTD PMID:33244087 and PMID:36519830 CXCL3 Human cannabidiol multiple interactions EXP 6480464 Cannabidiol inhibits the reaction [TNF protein results in increased expression of CXCL3 mRNA] CTD PMID:31250491 CXCL3 Human captopril multiple interactions EXP 6480464 Captopril inhibits the reaction [Glucose results in increased expression of CXCL3 mRNA] CTD PMID:38115276 CXCL3 Human carbon nanotube decreases expression EXP 6480464 Nanotubes and Carbon results in decreased expression of CXCL3 mRNA CTD PMID:23634900 CXCL3 Human CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to CXCL3 gene] CTD PMID:28238834 CXCL3 Human chondroitin sulfate multiple interactions EXP 6480464 Chondroitin Sulfates promotes the reaction [CTSK protein results in increased cleavage of CXCL3 protein] CTD PMID:25833952 CXCL3 Human cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of CXCL3 mRNA CTD PMID:23052192 CXCL3 Human copper atom multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in increased expression of CXCL3 mRNA CTD PMID:20971185 CXCL3 Human copper(0) multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in increased expression of CXCL3 mRNA CTD PMID:20971185 CXCL3 Human copper(II) chloride increases expression EXP 6480464 cupric chloride results in increased expression of CXCL3 mRNA CTD PMID:38568856 CXCL3 Human copper(II) sulfate affects expression EXP 6480464 Copper Sulfate affects the expression of CXCL3 mRNA CTD PMID:19549813 CXCL3 Human crocidolite asbestos increases expression EXP 6480464 Asbestos and Crocidolite results in increased expression of CXCL3 mRNA CTD PMID:18687144 more ... CXCL3 Human crotonaldehyde decreases expression EXP 6480464 2-butenal results in decreased expression of CXCL3 mRNA CTD PMID:20471460 CXCL3 Human cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of CXCL3 mRNA CTD PMID:20106945 and PMID:27989131 CXCL3 Human D-glucose multiple interactions EXP 6480464 Captopril inhibits the reaction [Glucose results in increased expression of CXCL3 mRNA] and huai qi huang inhibits the reaction [Glucose results in increased expression of CXCL3 mRNA] CTD PMID:38115276 CXCL3 Human D-glucose increases expression EXP 6480464 Glucose results in increased expression of CXCL3 mRNA CTD PMID:38115276 CXCL3 Human dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of CXCL3 mRNA CTD PMID:25047013 CXCL3 Human dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CXCL3 mRNA CTD PMID:28628672 CXCL3 Human diallyl trisulfide increases expression EXP 6480464 diallyl trisulfide results in increased expression of CXCL3 mRNA CTD PMID:34995734 CXCL3 Human dimethylarsinous acid increases expression EXP 6480464 dimethylarsinous acid results in increased expression of CXCL3 mRNA CTD PMID:23487506 CXCL3 Human dioxygen multiple interactions EXP 6480464 Oxygen inhibits the reaction [darinaparsin results in decreased expression of CXCL3 mRNA] CTD PMID:22535156 CXCL3 Human doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of CXCL3 mRNA CTD PMID:29803840 CXCL3 Human fulvestrant increases expression EXP 6480464 fulvestrant results in increased expression of CXCL3 mRNA CTD PMID:16298037 CXCL3 Human gemcitabine increases expression EXP 6480464 Gemcitabine results in increased expression of CXCL3 mRNA CTD PMID:17039268 CXCL3 Human glucose increases expression EXP 6480464 Glucose results in increased expression of CXCL3 mRNA CTD PMID:38115276 CXCL3 Human glucose multiple interactions EXP 6480464 Captopril inhibits the reaction [Glucose results in increased expression of CXCL3 mRNA] and huai qi huang inhibits the reaction [Glucose results in increased expression of CXCL3 mRNA] CTD PMID:38115276 CXCL3 Human hexadecanoic acid multiple interactions EXP 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of CXCL3 mRNA and [Palmitic Acid co-treated with Oleic Acid] affects the expression of CXCL3 mRNA CTD PMID:30547786 CXCL3 Human indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CXCL3 mRNA CTD PMID:28628672 CXCL3 Human iron(2+) sulfate (anhydrous) increases expression EXP 6480464 ferrous sulfate results in increased expression of CXCL3 mRNA CTD PMID:19428942 CXCL3 Human lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of CXCL3 mRNA CTD PMID:38568856 CXCL3 Human leflunomide increases expression EXP 6480464 leflunomide results in increased expression of CXCL3 mRNA CTD PMID:28988120 CXCL3 Human lipopolysaccharide multiple interactions EXP 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of CXCL3 mRNA more ... CTD PMID:21135123 more ... CXCL3 Human lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of CXCL3 mRNA CTD PMID:19428942 more ... CXCL3 Human manganese atom increases expression EXP 6480464 Manganese results in increased expression of CXCL3 mRNA CTD PMID:17175027 CXCL3 Human manganese(0) increases expression EXP 6480464 Manganese results in increased expression of CXCL3 mRNA CTD PMID:17175027 CXCL3 Human manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of CXCL3 mRNA CTD PMID:17175027 CXCL3 Human methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of CXCL3 mRNA CTD PMID:17379860 and PMID:21678067 CXCL3 Human methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of CXCL3 mRNA CTD PMID:24449571 CXCL3 Human methylisothiazolinone increases expression EXP 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of CXCL3 mRNA CTD PMID:31629900 CXCL3 Human methylparaben increases expression EXP 6480464 methylparaben results in increased expression of CXCL3 mRNA CTD PMID:17121429 CXCL3 Human nickel atom increases expression EXP 6480464 Nickel results in increased expression of CXCL3 mRNA CTD PMID:25583101 CXCL3 Human nickel dichloride increases expression EXP 6480464 nickel chloride results in increased expression of CXCL3 mRNA CTD PMID:17312168 CXCL3 Human nickel sulfate multiple interactions EXP 6480464 macrophage stimulatory lipopeptide 2 promotes the reaction [nickel sulfate results in increased expression of CXCL3 mRNA] and nickel sulfate promotes the reaction [macrophage stimulatory lipopeptide 2 results in increased expression of CXCL3 mRNA] CTD PMID:18832182 CXCL3 Human nickel sulfate increases expression EXP 6480464 nickel sulfate results in increased expression of CXCL3 mRNA CTD PMID:18832182 CXCL3 Human oleic acid multiple interactions EXP 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of CXCL3 mRNA and [Palmitic Acid co-treated with Oleic Acid] affects the expression of CXCL3 mRNA CTD PMID:30547786 CXCL3 Human ozone multiple interactions EXP 6480464 [Aripiprazole co-treated with Ozone] results in increased expression of CXCL3 mRNA CTD PMID:31476115 CXCL3 Human ozone increases expression EXP 6480464 Ozone results in increased expression of CXCL3 mRNA CTD PMID:31476115 CXCL3 Human paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CXCL3 mRNA CTD PMID:29067470 CXCL3 Human pentanal increases expression EXP 6480464 pentanal results in increased expression of CXCL3 mRNA CTD PMID:26079696 CXCL3 Human perfluorononanoic acid decreases expression EXP 6480464 perfluoro-n-nonanoic acid results in decreased expression of CXCL3 mRNA CTD PMID:38568856 CXCL3 Human perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of CXCL3 mRNA CTD PMID:38568856 CXCL3 Human perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CXCL3 mRNA CTD PMID:38568856 CXCL3 Human piroxicam decreases expression EXP 6480464 Piroxicam results in decreased expression of CXCL3 mRNA CTD PMID:19192274 and PMID:21858171 CXCL3 Human prednisolone decreases expression EXP 6480464 Prednisolone results in decreased expression of CXCL3 mRNA CTD PMID:19192274 CXCL3 Human Primycin increases expression EXP 6480464 primycin results in increased expression of CXCL3 mRNA CTD PMID:28916286 CXCL3 Human propanal increases expression EXP 6480464 propionaldehyde results in increased expression of CXCL3 mRNA CTD PMID:26079696 CXCL3 Human pterostilbene increases expression EXP 6480464 pterostilbene results in increased expression of CXCL3 mRNA CTD PMID:22450950 CXCL3 Human S-(1,2-dichlorovinyl)-L-cysteine multiple interactions EXP 6480464 [S-(1 more ... CTD PMID:35811015 CXCL3 Human serpentine asbestos increases expression EXP 6480464 Asbestos and Serpentine results in increased expression of CXCL3 mRNA CTD PMID:24160326 CXCL3 Human silicon dioxide increases expression EXP 6480464 Silicon Dioxide analog results in increased expression of CXCL3 mRNA and Silicon Dioxide results in increased expression of CXCL3 mRNA CTD PMID:19428942 more ... CXCL3 Human sodium arsenite multiple interactions EXP 6480464 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [sodium arsenite results in increased expression of CXCL3 mRNA] more ... CTD PMID:19349368 and PMID:24570342 CXCL3 Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of CXCL3 mRNA CTD PMID:19349368 more ... CXCL3 Human sodium aurothiomalate decreases expression EXP 6480464 Gold Sodium Thiomalate results in decreased expression of CXCL3 mRNA CTD PMID:19192274 CXCL3 Human tamoxifen decreases expression EXP 6480464 Tamoxifen results in decreased expression of CXCL3 mRNA CTD PMID:16298037 CXCL3 Human temozolomide decreases secretion EXP 6480464 temozolomide results in decreased secretion of CXCL3 protein CTD PMID:21509778 CXCL3 Human tert-butyl hydroperoxide increases expression EXP 6480464 tert-Butylhydroperoxide results in increased expression of CXCL3 mRNA CTD PMID:15336504 CXCL3 Human triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of CXCL3 mRNA CTD PMID:37042841 CXCL3 Human tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of CXCL3 mRNA CTD PMID:33545341 CXCL3 Human valproic acid decreases methylation EXP 6480464 Valproic Acid results in decreased methylation of CXCL3 gene CTD PMID:29154799 CXCL3 Human valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of CXCL3 mRNA CTD PMID:25979313 CXCL3 Human valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of CXCL3 mRNA CTD PMID:24383497 CXCL3 Human vanadyl sulfate increases expression EXP 6480464 vanadyl sulfate results in increased expression of CXCL3 mRNA CTD PMID:16330358 CXCL3 Human zinc atom decreases expression EXP 6480464 Zinc results in decreased expression of CXCL3 mRNA CTD PMID:18316168 CXCL3 Human zinc(0) decreases expression EXP 6480464 Zinc results in decreased expression of CXCL3 mRNA CTD PMID:18316168
